Nasdaq · CIK 0001516899
YTRA Yatra Online, Inc.
Insider trading from SEC Form 4. Last filing Aug 25, 2026.
In brief
Yatra Online, Inc. (YTRA) has 6 SEC Form 4 filings on file from 6 insiders, the latest filed on Aug 25, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
5 Form 144 notices of planned sales are on file, the latest filed Mar 5, 2024.
Last 90 days
Signals
Open-market buys and sells at Yatra Online, Inc., scored.
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 5, 2024 | Shringi Dhruv CEO | 37,500 0.06% of outstanding | $60k | Mar 4, 2024 | $122k |
| Feb 6, 2024 | Shringi Dhruv CEO | 37,500 0.06% of outstanding | $62k | Feb 5, 2024 | $117k |
| Jan 16, 2024 | Shringi Dhruv CEO | 37,500 0.06% of outstanding | $60k | Jan 8, 2024 | $135k |
| Dec 1, 2023 | Shringi Dhruv CEO | 37,500 0.06% of outstanding | $57k | Dec 1, 2023 | $252k |
| Nov 1, 2023 | Shringi Dhruv CEO | 52,500 0.09% of outstanding | $78k | Nov 1, 2023 | $180k |
Transactions
Every row filed, 9 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Murlidhara Kadaba director | AGrant or award Ordinary Shares | +16,305 | $0.00 | $0 | 134,004 | Aug 25, 2026 |
| Aug 24, 2026 | Michael A Kaufman director | AGrant or award Ordinary Shares | +13,871 | $0.00 | $0 | 61,585 | Aug 25, 2026 |
| Aug 24, 2026 | Roshan Mendis director | AGrant or award Ordinary Shares | +18,737 | $0.00 | $0 | 108,201 | Aug 25, 2026 |
| Aug 24, 2026 | Stephen Simon Schifrin director | AGrant or award Ordinary Shares | +18,737 | $0.00 | $0 | 194,112 | Aug 25, 2026 |
| Aug 5, 2026 | Siddhartha Gupta Chief Executive Officer | AGrant or award Ordinary Shares | +1,870,000 | $0.00 | $0 | 1,870,000 | Aug 6, 2026 |
| Aug 5, 2026 | Dhruv Shringi director | AGrant or award Performance Stock Unitsderivative | +256,410 | $0.00 | $0 | 256,410 | Aug 6, 2026 |
| Aug 5, 2026 | Dhruv Shringi director | AGrant or award Performance Stock Unitsderivative | +256,410 | $0.00 | $0 | 256,410 | Aug 6, 2026 |
| Aug 5, 2026 | Dhruv Shringi director | AGrant or award Performance Stock Unitsderivative | +256,410 | $0.00 | $0 | 256,410 | Aug 6, 2026 |
| Aug 5, 2026 | Dhruv Shringi director | AGrant or award Performance Stock Unitsderivative | +256,410 | $0.00 | $0 | 256,410 | Aug 6, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Siddhartha GuptaChief Executive Officer
- Murlidhara Kadabadirector
- Michael A Kaufmandirector, owner
- Roshan Mendisofficer, director
- Stephen Simon Schifrindirector
- Dhruv Shringidirector
Questions about YTRA
Answered from the filings on this page, as of the latest one.
Are insiders buying YTRA?
No. In the last 90 days no insider at Yatra Online, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade YTRA on the open market?
No open-market trade has been scored at Yatra Online, Inc.. The latest Form 4 on file was filed on Aug 25, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Yatra Online, Inc.?
6 people have filed a Form 4 at Yatra Online, Inc., among them Siddhartha Gupta (Chief Executive Officer), Murlidhara Kadaba (director), Michael A Kaufman (director and 10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.